Primary adenocarcinoma of the anus: A retrospective analysis

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 5, 1999, Pages 1199-1205

  Joon, Daryl Lim ^a   Chao, Michael W T ^a   Ngan, Samuel Y K ^a   Joon, Michael Lim ^a   Guiney, Michael J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Adenocarcinoma; Anal gland; Anus neoplasms; Chemotherapy; Radiotherapy

Indexed keywords

FLUOROURACIL; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RECTUM CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 0032761377     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00267-9     Document Type: Article

References (33)

1. Abel M.E., Chiu Y.S.Y., Russell T.R., Volpe P.A. Adenocarcinoma of the anal glands Results of a survey . Dis Colon Rectum. 36:1993;383-387.
2. Myerson R.J., Karnell L.H., Menck H.R. The National Cancer Data Base Report on carcinoma of the anus. Cancer. 80:1997;805-815.
3. Nielson O.V., Koch F. Carcinomas of the anorectal region of extramucosal origin with special reference to the anal ducts. Acta Chir Scand. 139:1973;299-305.
4. Tarazi R., Nelson R.L. Anal adenocarcinoma A comprehensive review . Semin Surg Oncol. 10:1994;235-240.
5. Rosser C. The relation of fistula in ano to cancer of the anal canal. Trans Am Proct Soc. 35:1934;65-71.
6. Fenger C., Morson B.C. Anal duct carcinoma. Dis Colon Rectum. 32:1989;355-357.
7. Parks A.G. Mucin secreting adenocarcinoma of anal gland origin. Br J Surg. 57:1970;434-436.
8. Shar T.G., Schein M. Anal canal adenocarcinoma A report of 4 cases . South African J Surg. 29:1991;164-166.
9. Getz S.B. Jr, Ough Y.D., Patterson R.B., Kovalcik P.J. Mucin adenocarcinoma developing in chronic anal fistula Report of two cases and review of the literature . Dis Colon Rectum. 24:1981;562-566.
10. Lee S.H., Zucker M., Sato T. Primary adenocarcinoma of an anal gland with secondary perianal fistulas. Hum Pathol. 12:1981;1034-1036.
11. Shindo K. Epidermoid carcinoma compared with adenocarcinoma of the anal canal. Aust N Z J Surg. 51:1981;426-429.
12. Leow C.K., Chung C.C., Lau W.Y., Li A.K. Malignant anal tumours in the Chinese population in Hong Kong. Surg Oncol. 5:1996;65-68.
13. Williams G., Talbot I.C. Anal carcinoma - a histological review. Histopathology. 25:1994;507-516.
14. Frisch M., Glimelius B., van den Brule A.J., et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 337:1997;1350-1358.
15. Koulos J., Symmans F., Chumas J., Nuovo G. Human papillomavirus detection in adenocarcinoma of the anus. Mod Pathol. 4:1991;58-61.
16. Zaren H.A., Delone F.X., Lerner H.J. Carcinoma of the anal gland Case report and review of the literature . J Surg Oncol. 13:1983;250-254.
17. Cummings B.J., et al. Epidermoid anal cancer Treatment by radiation alone or radiation and 5-fluorouracil with and without mitomycin C . Int J Radiat Oncol Biol Phys. 21:1991;1115-1125.
18. Mendenhall W.M., Sombeck M.D., Speer T.W., Marsh R.D., Carroll R.R., Copeland E.M. Current management of squamous cell carcinoma of the anal canal. Surg Oncol. 3:1994;135-146.
19. Rich T.A., Ajani J.A., Morrison W.H., Ota D., Levin B. Chemoradiation therapy for anal canal Radiation plus continuous infusion of 5-fluorouracil with or without cisplatin . Radiother Oncol. 27:1993;209-215.
20. Longo W.E., Vernava A.M. III, Wade T.P., Coplin M.A., Virgo K.S., Johnson F.E. Rare anal cancers in the US veteran Patterns of disease and results of treatment . Am Surg. 61:1995;495-500.
21. Anthony T., Simmang C., Lee E.L., Turnage R.H. Perianal mucinous adenocarcinoma. J Surg Oncol. 64:1997;218-221.
22. Barendsen G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 8:1982;1981-1997.
23. Travis E., Tucker S.L. Isoeffect models and fractionated radiation therapy. Int J Radiat Oncol Biol Phys. 13:1987;283-287.
24. Dale R.G. Time dependent tumour repopulation factors in linear quadratic equations Implications for treatment strategies . Radiother Oncol. 15:1989;371-382.
25. Dale R.G. The potential for radiobiological modelling in radiotherapy treatment design. Radiother Oncol. 19:1990;245-255.
26. Withers H.R., Taylor J.M.G., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:1998;131-146.
27. Statistical sciences. S-PLUS Version 3.3 for Windows. 1995;StatSci, Seattle, WA.
28. Berg H.K. Case report Adenocarcinoma of the anal canal . Maryland Med J. 39:1990;675-678.
29. Behan W.M.H., Burnett R.A. Adenocarcinoma of the anal glands. J Clin Pathol. 49:1996;1009-1011.
30. Jensen S.L., Shokouh-Amiri M.H., Hagen K., et al. Adenocarcinoma of the anal ducts A series of 21 cases . Dis Colon Rectum. 31:1988;268-272.
31. Beahrs O.H., Wilson S.M. Ann Surg. 184:1976;422-428.
32. Cabrera A., Tsukada Y., Pickren J.W. Adenocarcinoma of the anal canal and perianal tissues. Ann Surg. 164:1966;152-156.
33. Basik M., Rodriguez-Bigas M.A., Penetrante R., Petrelli N.J. Prognosis and recurrence patterns of anal adenocarcinoma. Am J Surgery. 160:1995;223-237.